Email Facebook Twitter Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulants Title Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulants Author Kemme, M.J.B. Faaij, R.A. Schoemaker, R.C. Kluft, C. Meijer, P. Cohen, A.F. Burggraaf, J. Gaubius Instituut TNO Publication year 2001 Abstract During studies on warfarin, heparin and various anticoagulants with novel mechanisms of action, the activated partial thromboplastin time (aPTT) and the (apparent) international normalized ratio (INR) from a bedside monitor (Coagucheck Plus®) were compared with laboratory assay results. Data were compared using the Bland and Altman method of comparison where systematic differences result in significant slopes of the regression line. During heparin treatment, the bedside monitor largely underestimated the aPTT (slope=-0.80). During treatment with the direct thrombin inhibitor napsagatran (slope=0.99), the pentasaccharides Org31540/SR90107A (slope=0.77) and SanOrg34006 (slope=0.35), and warfarin (slope=0.60), the bedside monitor underestimated the aPTT at lower aPTT levels, while at higher aPTT levels it overestimated the laboratory values. The bedside monitor slightly overestimated the INR during treatment with warfarin (slope=0.33). Apparent INR was largely overestimated during treatment with Org31540/SR90107A (slope=1.38), SanOrg34006 (slope=0.97), Napsagatran (slope=1.23), and recombinant tissue factor pathway inhibitor (slope=1.48, P < 0.001 for all regression lines). These results indicate that a substantial disagreement in aPTT or (apparent) INR exists between the bedside monitor and laboratory assay during treatment with the studied 'classic' and novel anticoagulants. The amount of disagreement depended on the anticoagulant given. © 2001 Lippincott Williams & Wilkins. Chemicals/CAS: Anticoagulants; Antithrombins; Fibrinolytic Agents; Heparin, 9005-49-6; Naphthalenes; Oligosaccharides; Org 31540, 104993-28-4; Piperidines; Ro 46-6240; SANORG 34006; Warfarin, 81-81-2 Subject Activated partial thromboplastin timeBedside monitorInternational normalized ratioProthrombin timeAnticoagulant agentFondaparinuxNapsagatranRecombinant tissue factor pathway inhibitorAdultBlood clotting parametersBlood samplingClinical articleIntermethod comparisonLaboratory testOutpatient carePartial thromboplastin timeProthrombin timeThromboembolismAnticoagulantsAntithrombinsDrug MonitoringFalse Negative ReactionsFalse Positive ReactionsFibrinolytic AgentsHeparinHumansLaboratoriesNaphthalenesOligosaccharidesPartial Thromboplastin TimePiperidinesPoint-of-Care SystemsReproducibility of ResultsWarfarin To reference this document use: http://resolver.tudelft.nl/uuid:77c0d5be-cacf-4165-80ce-2f733063ffd1 DOI https://doi.org/10.1097/00001721-200110000-00012 TNO identifier 236278 ISSN 0957-5235 Source Blood Coagulation and Fibrinolysis, 12 (7), 583-591 Document type article Files To receive the publication files, please send an e-mail request to TNO Library.